Displaying 1–25 of 8032 results for

Sort By Relevance Sort By Date
1 2 3 4 5 ...322

Celgene partners with immuno-oncology startup

(News)

Celgene has entered into a global strategic collaboration with Kyn Therapeutics, a Boston-based clinical-stage biotech, to develop immuno-oncology therapies.

Tax authority demands retroactive taxes from Teva

(News)

The Israel Tax Authority intends to demand that Teva Pharma hands over NIS $1 billion ($271 million) in retroactive tax for 2014-2015, according to sources connected to an Israeli financial publication.

Top 5 Drugs With the Biggest Growth Potential in 2019

(Article)

In the coming year, several drugs that treat a range of diseases will far surpass the $1 billion blockbuster mark and continue to grow.

Bayer to shutter Pennsylvania site, jeopardizing 600 jobs

(News)

Amid restructuring efforts related to its $63 billion acquisition of Monsanto, Bayer has decided to shutter a facility outside of Pittsburgh.

FDA could run out of funds for drug approvals in five weeks

(News)

As the government shutdown drags on, the clock is ticking on the FDA’s ability to process drug approval applications.

400 FDA workers return to posts mid-shutdown

(News)

About 100 of the returning staff will be concentrating on inspections of high-risk medical device manufacturing facilities, about 70 focused on inspections of high-risk drug manufacturing facilities and about 90 focused on inspections of high-risk biological manufacturing facilities

Roche R&D exec leaves pharma for biotech, joins Voyager Therapeutics

(News)

Voyager Therapeutics appoints Omar Khwaja as its chief medical officer, leaving a post at Roche as global head of neuroscience translational medicine and global head of rare diseases

Curing Batch Record Pain Points

(Article)

How innovative EBR solutions are making it easier to scrap paper-based processes

Allergan adds R&D facility in Massachusetts

(News)

Allergan announced it will establish an R&D presence in the Kendall Square section of Cambridge, Massachusetts.

AstraZeneca CMO departs as reorg continues

(News)

AstraZeneca's chief medical officer, Sean Bohen is leaving after less than four years at the company, amid the drugmaker's newly announced overhaul.

China hit with fresh vaccination scandal

(News)

Health officials in China announced this week that they are investigating why 145 babies were given expired polio vaccines earlier this month.

House Democrats to investigate pricing policies of 12 major drug companies

(News)

As political pressure mounts to combat drug costs, a House Oversight Committee has announced that it will probe the pricing policies of 12 major companies.

J&J raises U.S. drug prices

(News)

Johnson & Johnson raised U.S. prices on around two dozen drugs, including psoriasis treatment, Stelara, prostate cancer drug, Zytiga, and blood thinner, Xarelto.

The Shutdown and the FDA: What Pharma Companies Need to Know

(Article)

In the process of working with the FDA? Expect delays.

AstraZeneca announces plant closings, layoffs

(News)

AstraZeneca will be closing two manufacturing sites in Colorado in order to consolidate its biologics manufacturing network in one large-scale drug substance facility.

NICE rejects Novartis migraine drug

(News)

Britain's National Institute for Health and Care Excellence (NICE) rejected Novartis’s migraine drug, Aimovig, concluding that the drug was not a cost-effective use of resources.

Akorn hit with warning letter from FDA

(News)

The FDA has followed up a Form 483 to Akron Inc. with a warning letter.

Pfizer to shutter troubled plants in India

(News)

Pfizer has decided to call “time of death” on two Indian plants the company took over after its acquisition of Hospira in 2015.

Best and Worst Places to Find STEM Jobs

(Article)

New WalletHub analysis ranks 2019’s Best & Worst Metro Areas for STEM Professionals

Sage hits major trial goal with potential blockbuster drug

(News)

Sage Therapeutics reported positive results this week from a trial for a new type of antidepressant.

Supreme Court signals support for Merck in major case

(News)

Merck & Co. could be close to winning a Supreme Court case that could set an important precedent for future product liability claims.

Eli Lilly lets go of 250 in France

(News)

The drugmaker currently employs 1,400 workers at the plant in Eastern France.

Takeda will keep OTC biz even after closing costly Shire deal

(News)

While the Takeda is seeing pressure to improve finances, chief executive Christophe Weber said that a sale of its OTC business is not a current priority.

AstraZeneca appoints controversial R&D leader

(News)

AstraZeneca has appointed well-known but controversial cancer doctor, José Baselga, to head research and development for oncology, as part of a larger overhaul designed to speed drugs to market

Sort By Relevance Sort By Date
1 2 3 4 5 ...322